| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.4 | 0.01 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |